PI3K/Akt/mTOR pathway inhibitors in cancer: a perspective on clinical progress.
Wu
P
P
ZJU-ENS Joint Laboratory of Medicinal Chemistry, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Hu
Y-Z
YZ